Image Source: AsiaOne
Adagene to Participate in the Jefferies Virtual China Biotech SummitGlobeNewswireOctober 21, 2021SAN FRANCISCO and SUZHOU, China, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that Adagene’s Co-founder, Chief Executive Officer and Chairman, Peter Luo, Ph.D., will provide a corporate update and participate in one-on-one investor meetings at the Jefferies Virtual China Biotech Summit to be held October 26, 2021. Details on the presentation include: Date: Tuesday, October 26, 2021 Presentation Time: 3:00 p.m. Eastern
Source: AsiaOne